期刊文献+

非小细胞肺癌个体化分子靶向治疗研究进展

下载PDF
导出
摘要 近年来,基因检测实验技术的提高为分子生物学的快速发展提供了基础,多种基因突变与表达异常等分子机制已经被证实与非小细胞肺癌(nonsmall cell lung cancer,NSCLC)的发病、耐药相关。目前,以基因检测为依据的个体化靶向治疗在临床上取得了较好的效果,NSCLC正在向个体化治疗的精准医学时代迈进,
出处 《北京医学》 CAS 2017年第3期286-290,共5页 Beijing Medical Journal
基金 吴阶平医学基金会临床科研专项(320.6570.1375)
  • 相关文献

参考文献5

二级参考文献72

  • 1余宗阳,杜建,兰凤华,欧阳学农,李慧忠.胰岛素样生长因子Ⅰ受体α链靶向阻断对肺腺癌细胞SPC-A-1的影响[J].中国癌症杂志,2004,14(3):212-216. 被引量:4
  • 2余宗阳,欧阳学农,杜建,季天海,李捷.非小细胞肺癌胰岛素样生长因子Ⅰ受体的表达及其临床意义[J].中国癌症杂志,2006,16(8):638-640. 被引量:6
  • 3丁磊,陈孝平,张志伟,靖凯,曹斌,朱鹏,李杰,张德勇.溴隐亭联合肿瘤坏死因子-α对人肝癌耐药细胞株化疗敏感性的影响[J].中华外科杂志,2006,44(23):1644-1647. 被引量:4
  • 4Zhang H, Yee D. Is the type I insulin- like growth factor receptor a therapeutic target in endometrial cancer Clin Cancer Res. 2006, 12 (21): 6323-5.
  • 5Maorano E, CiampoliUo A, Viale G, et 81. Insulin- like growth factor Iexpression in thyrod tumors. Appl Immunohis- tochem. Molecul Morohol. 2000. 8 (2): 110.
  • 6Moschos SJ, Mantzoros CS.The role of the IGF system in cancer: from basic to clinical studies and clinical applications.Onoology.2002, 63 (4) : 317 - 32.
  • 7Guerra FK, Eijan AM, PuriceUi L. Varying patterns of expression of insulin - like growth factor I and II and their receptors in murinc mammary adenocarcinomas of different metastasizing ability. Int J Cancer, 1996, 65 (6): 812.
  • 8Long L, Rubin R, Brodt P. Enhanced invasion and liver coloniza- tion by lung carcinoma cells overexpressing the type 1 insulin - like growth factor reeeptor. Exp Cell Res, 1998, 238 (1): 116.
  • 9Ji H,Zhao X,Yuza Y,et al.Epidermal growth factor receptor variant Ⅲ mutations in lung tumorigenesis and sensitivity to tyrosine kinase Inhibitors.Proc Natl Acad Sci U S A,2006,103:7817-7822.
  • 10Weiss J,Sos ML,Seidel D,et al.Frequent and focal FGFR1 amplification associates with therapeutially tractable FGFR1 dependency in squamous cell lung cancer.Sci Transl Med,2010,2:62ra 93.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部